Oriola-KD to distribute Pfizer's pharmaceuticals in Sweden

Oriola-KD Corporation Stock Exchange Release 12 July 2006 at 09.00 a.m.

Kronans Droghandel AB, a subsidiary of Oriola-KD Group has signed an agreement
with Pfizer AB on the distribution of Pfizer's Rx (prescribed) pharmaceuticals
in Sweden. According to the new agreement Oriola-KD will distribute all
Pfizer's Rx pharmaceuticals in Sweden as of the second quarter 2007. Oriola-KD
is currently distributing approximately half of Pfizer's pharmaceuticals in
Sweden. 

The market share of Pfizer in the Swedish pharmaceutical market in June 2006
was 9.2 per cent (9.4 per cent during January-June 2006), which makes Pfizer
the largest pharma company in Sweden (source: IMS Health). 

Oriola-KD's market share in the Swedish pharma distribution in June 2006 was
43.9 per cent (43.8 per cent during January-June 2006), (source: IMS Health). 

Oriola-KD Corporation


Eero Hautaniemi Kimmo Virtanen
President and CEO CFO


For further information please contact:

Oriola-KD Corporation
Kimmo Virtanen, CFO
Tel. +358 10 429 2069
Email: kimmo.virtanen@oriola.com

Distribution:
Helsinki Stock Exchange
Major Media

Publisher:
Oriola-KD Corporation
Corporate Communications
Harmaaparrankuja 1
FI-02200 Espoo
Finland
www.oriola-kd.fi